DYSPLASTIC GANGLIOCYTOMA OF CEREBRELLUM

Clinical trials for DYSPLASTIC GANGLIOCYTOMA OF CEREBRELLUM explained in plain language.

Never miss a new study

Get alerted when new DYSPLASTIC GANGLIOCYTOMA OF CEREBRELLUM trials appear

Sign up with your email to follow new studies for DYSPLASTIC GANGLIOCYTOMA OF CEREBRELLUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Tracking Kids' health years after brain tumor treatment

Disease control Ongoing

This study follows children and teens who are already taking the medications dabrafenib and/or trametinib for various types of brain tumors. The main goal is to monitor their long-term health, safety, and development while they continue treatment. Researchers will track side effe…

Matched conditions: DYSPLASTIC GANGLIOCYTOMA OF CEREBRELLUM

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

DYSPLASTIC GANGLIOCYTOMA OF CEREBRELLUM

Get alerted when new DYSPLASTIC GANGLIOCYTOMA OF CEREBRELLUM trials appear

Tracking Kids' health years after brain tumor treatment